Abstract
The relationship between multiple sclerosis (M.S.) and some specific HLA system antigens is now a proven fact, showing in the caucasoids population an increase in B7 and DR2 alleles in the M.S. populations.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Engell T., Raun N.E., Thomsen, M., Platz P. 1982 HLA Heterogeneity of multiple sclerosis. Neurology 32, 1043–1046.
Fauchet R., Madigand M., Gueguen-Duchesne MY., Papin J., Sabouraud O., Genetet B., 1984. Les marqueurs Bf et C4 du complèment dans la sclérose en plaques 140, 6–7 422–425.
Kurtzke J.F. 1983 Rating neurologie impairment in M.S., an expanding disability scale. Neurology 33 p 1444–1452.
Madigand M., Oger J., Fauchet R., Sabouraud O., 1982. HLA profiles in M.S. suggest two forms of disease and the existence of protective haplotypes. Journal of Neurological Sciences, 53, 519–529.
Poser C., Paty D., Scheinberg L., Mc Donald WT et Al 1982. New diagnostic criteria of M S. Workshop Washington. Ann. Neurol. 13: 227–231.
Wentzel J., Roberts DF, Bates D. 1984. Multiple sclérosis, HLA and lymphocyte surface markers. Acta Neurol. Scand 69: 65–73.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 ECSC, EEC, EAEC, Brussels and Luxembourg
About this chapter
Cite this chapter
Merienne, M. et al. (1986). HLA Markers and Course of Disease in Multiple Sclerosis. In: Hommes, O.R. (eds) Multiple Sclerosis Research in Europe. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4143-4_43
Download citation
DOI: https://doi.org/10.1007/978-94-009-4143-4_43
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8338-6
Online ISBN: 978-94-009-4143-4
eBook Packages: Springer Book Archive